Serum uric acid and other short-term predictors of electrocardiographic alterations in the Brisighella Heart Study cohort

European Journal of Internal Medicine

Volumn 26, Issue 4, 2015, Pages 255-258

  Cicero, Arrigo F G ^a,d   Rosticci, Martina ^a,d   Tocci, Giuliano ^b,c,d   Bacchelli, Stefano ^a,d   Urso, Riccado ^a,d   D'Addato, Sergio ^a,d   Borghi, Claudio ^a,d  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c IRCCS NEUROMED   (Italy)

^d Brisighella Heart Study Group   (Italy)

Author keywords

Arrhythmias; Electrocardiogram; Epidemiology; Serum uric acid

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; URIC ACID;

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; BODY MASS; BRADYCARDIA; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; ELECTROCARDIOGRAM; FEMALE; FOLLOW UP; GENDER; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; HEALTH SURVEY; HEART INFARCTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART PROTECTION; HEART RATE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; PHYSICAL ACTIVITY; PROGNOSIS; Q WAVE; SINUS BRADYCARDIA; SINUS TACHYCARDIA; SMOKING; TACHYCARDIA; TRIACYLGLYCEROL BLOOD LEVEL; URIC ACID BLOOD LEVEL; VERY ELDERLY; BLOOD; COHORT ANALYSIS; ELECTROCARDIOGRAPHY; HYPERTROPHY, LEFT VENTRICULAR; ITALY; MIDDLE AGED; MYOCARDIAL INFARCTION; REGRESSION ANALYSIS; RISK FACTOR;

AGED; COHORT STUDIES; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; ITALY; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROGNOSIS; REGRESSION ANALYSIS; RISK FACTORS; TACHYCARDIA; URIC ACID;

EID: 84928829370     PISSN: 09536205     EISSN: 18790828     Source Type: Journal    
DOI: 10.1016/j.ejim.2015.02.007     Document Type: Article

References (29)

1. M. Jin, F. Yang, and I. Yang, et al. Uric acid, hyperuricemia and vascular diseases Front Biosci 17 2012 656 669
2. N. Katsiki, A. Karagiannis, and V.G. Athyros, et al. Hyperuricaemia: more than just a cause of gout? J Cardiovasc Med 14 2013 397 402
3. G. Zhao, L. Huang, and M. Song, et al. Baseline serum uric acid level as a predictor of cardiovascular disease related mortality and all-cause mortality: a meta-analysis of prospective studies Atherosclerosis 231 2013 61 68
4. A. Dutta, W. Henley, and L.C. Pilling, et al. Uric acid measurement improves prediction of cardiovascular mortality in later life J Am Geriatr Soc 61 2013 319 326
5. Z. Soltani, K. Rasheed, and D.R. Kapusta, et al. Potential role of uric acid in metabolic syndrome, hypertension, kidney injury, and cardiovascular diseases: is it time for reappraisal? Curr Hypertens Rep 15 2013 175 181
6. P.F. Hsu, S.Y. Chuang, and H.M. Cheng, et al. Associations of serum uric acid levels with arterial wave reflections and central systolic blood pressure Int J Cardiol 168 2013 2057 2063
7. A.F. Cicero, P. Salvi, S. D'Addato, et al. The Brisighella Heart Study group Association between serum uric acid, hypertension, vascular stiffness and subclinical atherosclerosis: data from the Brisighella Heart Study J Hypertens 32 2014 57 64
8. L. Tamariz, S. Agarwal, and E.Z. Soliman, et al. Association of serum uric acid with incident atrial fibrillation (from the Atherosclerosis Risk in Communities [ARIC] study) Am J Cardiol 108 2011 1272 1276
9. F. Valbusa, L. Bertolini, and S. Bonapace, et al. Relation of elevated serum uric acid levels to incidence of atrial fibrillation in patients with type 2 diabetes mellitus Am J Cardiol 112 2013 499 504
10. A.F. Cicero, M. Rosticci, A. Reggi, et al. the Brisighella Heart Study group Relationship between serum uric acid and electrocardiographic alterations in a large sample of general population: data from the Brisighella Heart Study High Blood Press Cardiovasc Prev 2014 Epub ahead of print
11. A.F.G. Cicero, A. Dormi, and S. D'Addato, et al. On behalf of the Brisighella Heart Study Staff. From risk factor assessment to cardiovascular disease risk and mortality modification: the first 40 years of the Brisighella Heart Study Clin Lipidol 6 2011 269 276
12. A.S. Levey, L.A. Stevens, and C.H. Schmid, et al. CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration). A new equation to estimate glomerular filtration rate Ann Intern Med 150 2009 604 612
13. P.M. Rautaharju, P.J. MacInnis, and J.W. Warren, et al. Methodology of ECG interpretation in the Dalhousie program; NOVACODE ECG classification procedures for clinical trials and population health surveys Methods Inf Med 29 1990 362 374
14. G. Mancia, R. Fagard, and K. Narkiewicz, et al. Task Force Members. 2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) J Hypertens 31 2013 1281 1357
15. S.L. Rodrigues, L.C. Angelo, and M.P. Baldo, et al. Detection of left ventricular hypertrophy by the R-wave voltage in lead aVL: population-based study Clin Res Cardiol 102 2013 653 659
16. K. Thygesen, J.S. Alpert, and A.S. Jaffe, et al. Writing Group on the Joint ESC/ACCF/AHA/WHF Task Force for the Universal Definition of Myocardial Infarction. Third universal definition of myocardial infarction Eur Heart J 33 2012 2551 2567
17. I. Simera, D. Moher, and J. Hoey, et al. A catalogue of reporting guidelines for health research Eur J Clin Invest 40 2010 35 53
18. J.M. Ritter Cardiac safety, drug-induced QT prolongation and torsade de pointes (TdP) Br J Clin Pharmacol 73 2012 331 334
19. A. Nyrnes, I. Toft, and I. Njølstad, et al. Uric acid is associated with future atrial fibrillation: an 11-year follow-up of 6308 men and women - the Tromso Study Europace 16 2014 320 326
20. A.M. Shehab, R. Butler, and R.J. MacFadyen, et al. A placebo-controlled study examining the effect of allopurinol on heart rate variability and dysrhythmia counts in chronic heart failure Br J Clin Pharmacol 51 4 2001 329 334
21. J.A. Honorat, M. Kinoshita, and T. Okuno, et al. Xanthine oxidase mediates axonal and myelin loss in a murine model of multiple sclerosis PLoS One 8 8 2013 e71329
22. I. Holme, A.H. Aastveit, and N. Hammar, et al. Uric acid and risk of myocardial infarction, stroke and congestive heart failure in 417,734 men and women in the Apolipoprotein MOrtality RISk study (AMORIS) J Intern Med 266 6 2009 558 570
23. H. Huang, B. Huang, and Y. Li, et al. Uric acid and risk of heart failure: a systematic review and meta-analysis Eur J Heart Fail 16 2014 15 24
24. S. Fujita, Y. Okamoto, and K. Shibata, et al. Serum uric acid is associated with left ventricular hypertrophy independent of serum parathyroid hormone in male cardiac patients PLoS One 8 2013 e82735
25. H. Mitsuhashi, H. Yatsuya, and K. Matsushita, et al. Uric acid and left ventricular hypertrophy in Japanese men Circ J 73 2009 667 672
26. F. Viazzi, D. Parodi, and G. Leoncini, et al. Serum uric acid and target organ damage in primary hypertension Hypertension 45 2005 991 996
27. S.N. Ofori, and O.J. Odia Serum uric acid and target organ damage in essential hypertension Vasc Health Risk Manag 10 2014 253 261
28. M. Alderman, and K.J. Aiyer Uric acid: role in cardiovascular disease and effects of losartan Curr Med Res Opin 20 2004 369 379
29. S. Sciarretta, R. Pontremoli, and E.A. Rosei, et al. Independent association of ECG abnormalities with microalbuminuria and renal damage in hypertensive patients without overt cardiovascular disease: data from Italy-Developing Education and awareness on MicroAlbuminuria in patients with hypertensive Disease study J Hypertens 27 2009 410 417